Munich, 01 December 2016
The former member of the board of Sandoz / Hexal AG Dr Gerhard Schaefer becomes an advisory board member of Entourage.
The management and human resources consultancy Entourage gains Dr Gerhard Schaefer for its advisory board as of 1 December 2016. Dr Schaefer has more than 30 years of experience in the generic pharmaceutical industry in leading positions in development, quality assurance and control as well as business development at such well-known companies as Azupharma, Knoll, Stada, HEXAL and Sandoz. From 2005 to 2012, Dr Schaefer was Managing Director of Sandoz International and Head of Global Product Development and Global Business Development, responsible for eleven global development centres. In 2013, Dr Schaefer set up his own business as an advisor and consultant for portfolio selection and product development and has since worked for various pharmaceutical companies in Germany and other European countries.
The renowned pharmaceutical manager is looking forward to his advisory board activities at Entourage. "In my advisory board activities, it is important for me not to be exposed to any conflicts of interest. With the advisory board mandate of a personnel and management consulting company, I occupy a market segment in which I have not taken on any mandates to date. Entourage convinced me with its unique consulting approach: the combination of strategic competence with an operative hands-on mentality."
Dominik M. Aumer, Managing Partner, is proud of this honourable addition. "With Dr. Gerhard Schaefer, we have been able to win another recognised personality from the pharmaceutical industry for our advisory board. His career speaks for itself. His down-to-earthness and humanity has inspired us and enriches the culture of the Entourage."
Short profile Dr Gerhard Schaefer
Dr Gerhard Schaefer received his doctorate in organic chemistry from the University of Stuttgart in 1981. After his first professional positions in management in the areas of pharmaceutical development, quality control and quality assurance, he held management positions in business development at well-known companies such as Azupharma, Knoll, Stada, HEXAL and Sandoz. After being appointed to the Executive Board of HEXAL AG in 2003, Dr Schaefer advanced to become Managing Director of Sandoz International and Head of Global Product Development and Global Business Development following the acquisition of HEXAL AG by Novartis / Sandoz in 2005. In the period from 2005 to 2012, Dr Schaefer was responsible for eleven global development sites. Since 2013, Dr Gerhard Schaefer has worked as a freelance advisor and consultant for portfolio selection and product development at pharmaceutical companies in Germany, France and Poland.
Short profile Entourage
Entourage is a management and recruitment consultancy specialising in all natural science disciplines in the pharmaceutical and medical technology industries. With the placement of permanent employees and freelancers, as well as the supply of highly qualified natural scientists, the company, based in Munich, Zug and Basel, recruits experts for the leading life science companies in Germany, Austria and Switzerland. With the European Experts Network (EEN), Entourage taps into a Europe-wide potential of employees, freelancers and interim managers. With the Entourage Task Force (ETF), Entourage bundles selected interim managers into a high-calibre consulting unit that realises pharmaceutical and medical technology solution scenarios in an interdisciplinary manner in consulting projects.